In DETECT AS, the passive notifications improved rates of AVR and boosted survival, with bigger gains in women.

The once-monthly drug is still under study but could provide added convenience and another option for patients.

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

The observational data can’t capture details like the timing, amount, and type of exposure. Still, there’s a “safety signal.” ...

Elevations in cardiac troponin (cTn) after long bouts of aerobic exercise are not associated with subclinical coronary artery ...

These data suggest that private equity-acquired hospitals are cherry-picking the healthiest patients as part of an effort to ...

Most cases are subclinical, but given the newness of the therapy, it’s necessary to keep tabs on the issue going forward.

Outcomes in the observational study were better among patients treated by surgeons who regularly do ablations.

Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI ...

The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age.